C57BL/6N-Bap1tm1c(EUCOMM)Hmgu/WtsiPh
Status | Available to order |
EMMA ID | EM:14399 |
International strain name | C57BL/6N-Bap1tm1c(EUCOMM)Hmgu/WtsiPh |
Alternative name | HEPD0526_2_G01 |
Strain type | Targeted Mutant Strains : Targeted Conditional |
Allele/Transgene symbol | Bap1tm1c(EUCOMM)Hmgu |
Gene/Transgene symbol | Bap1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This line originates from EUCOMM ES clone HEPD0526_2_G01, after breeding with a Flp recombinase deleter line to convert the original targeted allele tm1a (knock-out first allele) into a conditional allele tm1c. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Uveal melanoma / Orphanet_39044
- BAP1-related tumor predisposition syndrome / Orphanet_289539
- Meningioma / Orphanet_2495
- Pleural mesothelioma / Orphanet_50251
- Non-specific syndromic intellectual disability / Orphanet_528084
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased mammary adenocarcinoma incidence / MGI
- no phenotypic analysis / MGI
- embryonic growth retardation / MGI
- increased squamous cell carcinoma incidence / MGI
- increased incidence of tumors by chemical induction / MGI
- hematopoietic system phenotype / MGI
- increased ovary tumor incidence / MGI
- increased lung carcinoma incidence / MGI
- abnormal DNA methylation / MGI
- increased skin tumor incidence / MGI
- increased mesothelioma incidence / MGI
- increased pancreatic islet cell carcinoma incidence / MGI
- embryonic lethality between implantation and placentation, complete penetrance / MGI
- embryonic lethality during organogenesis, complete penetrance / MGI
- abnormal epigenetic regulation of gene expression / MGI
- increased granulosa cell tumor incidence / MGI
- increased lymphoma incidence / MGI
- increased colon tumor incidence / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).